ACTIVE SUBSTANCE / INN

LOTEPREDNOL ETABONATE

Brand name(s): INVELTYS, LOTEMAX SM, ALREX, LOTEPREDNOL ETABONATE AND TOBRAMYCIN, ZYLET, LOTEPREDNOL ETABONATE, LOTEMAX, EYSUVIS
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA213956
ANDA215203
ACTIVE SUBSTANCE
Loteprednol Etabonate
REGULATORS
FDA
SPONSORS / MAH
ALCON LABS INC, BAUSCH AND LOMB, PHARMOS
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LOTEMAX SMNDA208219BAUSCH AND LOMB INCPrescription
LOTEPREDNOL ETABONATEANDA215203PADAGIS USPrescription
ZYLETNDA050804BAUSCH AND LOMBPrescription
LOTEPREDNOL ETABONATEANDA213956HIKMADiscontinued
LOTEMAXNDA020583BAUSCH AND LOMBPrescription
ALREXNDA020803BAUSCH AND LOMBPrescription
LOTEPREDNOL ETABONATE AND TOBRAMYCINANDA217597ALEMBICPrescription
INVELTYSNDA210565ALCON LABS INCPrescription
EYSUVISNDA210933ALCON LABS INCPrescription
LOTEMAXNDA020841PHARMOSDiscontinued

FULL INTELLIGENCE ON LOTEPREDNOL ETABONATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →